NCT06554171 Hippotherapy Simulators on Trunk Control and Upper Extremity Functions in Cerebral Palsy
| NCT ID | NCT06554171 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Firat University |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2024-10-20 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The hippotherapy simulator imitates the three-dimensional mechanical movement and walking of the horse and transfers the mechanical effect to the rider during hippotherapy. The aim of this study was to investigate the effect of exercise program with hippotherapy simulator on upper extremity functions and trunk control of individuals with cerebral palsy.All individuals diagnosed with Cerebral Palsy who agree to participate in the study and meet the inclusion criteria will be randomly divided into two groups as Study and Control Group. In addition to conventional physiotherapy, the study group will be trained in the Hippotherapy Simulature for 15 minutes a day, 5 days a week for 4 weeks.n addition to conventional physiotherapy, the control group will be allowed to sit in the Hippotherapy Simulature for 15 minutes a day, 5 days a week for 4 weeks. However, the simulator will be kept in closed position to prevent oscillations.
Eligibility Criteria
Inclusion Criteria: * Being between 6-18 years old * Being diagnosed with unilateral spastic type cerebral palsy * Voluntariness of the family and individuals to participate in the study * Being at I, II, III level according to the Hand Skills Classification System * To have the cognitive development to cooperate Exclusion Criteria: * Having undergone any orthopedic and/or neurological surgery and/or BoNT A operation within the last 6 months * Having a history of epilepsy * Hearing and/or vision loss at a level that prevents participation in the study
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.